The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer

By McKeage Mark J  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 1, 2008-01 ,pp. : 23-29

Informa Healthcare

Access to resources Recommend Favorite

Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer

By Tsintavis Athanassios   Lambou Theocharis   Vacalicos John   Koutsilieris Michael   Karamanolakis Dimitrios   Bogdanos John   Milathianakis Constantine   Mitsiades Constantine   Dimopoulos Theodoros  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 2, 2002-02 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

The Combination of New Immunotherapy and Radiotherapy: A N ew Potential Treatment for Locally Advanced Non-Small Cell Lung Cancer

By  

Current Clinical Pharmacology, Vol. 12, Iss. 1, 2017-06 ,pp. : 4-10

Bentham Science Publishers

Access to resources Recommend Favorite

The Treatment of Advanced Prostate Cancer with Ketoconazole: Safety Issues

By Bok R.A.   Small E.J.  

Drug Safety, Vol. 20, Iss. 5, 1999-05 ,pp. : 451-458

Adis International

Access to resources Recommend Favorite

A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer

By Moulder Stacy   Dhillon Navneet   Ng Chaan   Hong David   Wheler Jennifer   Naing Aung   Tse Susan   La Paglia Amy   Dorr Robert   Hersh Evan   Boytim Michelle   Kurzrock Razelle  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 634-640

Springer Publishing Company

Access to resources Recommend Favorite